Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis.
|
Sci Transl Med
|
2010
|
4.95
|
2
|
Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology.
|
J Allergy Clin Immunol
|
2006
|
3.86
|
3
|
Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus.
|
PLoS Med
|
2006
|
2.53
|
4
|
Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans.
|
J Clin Invest
|
2003
|
2.27
|
5
|
Defective lymphocyte chemotaxis in beta-arrestin2- and GRK6-deficient mice.
|
Proc Natl Acad Sci U S A
|
2002
|
2.26
|
6
|
Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival.
|
Blood
|
2002
|
2.11
|
7
|
Beta-arrestin-2 regulates the development of allergic asthma.
|
J Clin Invest
|
2003
|
1.85
|
8
|
Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling.
|
Blood
|
2006
|
1.83
|
9
|
Cerebral palsy is characterized by protein mediators in cord serum.
|
Ann Neurol
|
2004
|
1.73
|
10
|
Prolonged CD4+ cell/virus load discordance during treatment with protease inhibitor-based highly active antiretroviral therapy: immune response and viral control.
|
J Infect Dis
|
2003
|
1.71
|
11
|
Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens.
|
Arthritis Rheum
|
2006
|
1.62
|
12
|
CX3CR1 deficiency impairs dendritic cell accumulation in arterial intima and reduces atherosclerotic burden.
|
Arterioscler Thromb Vasc Biol
|
2007
|
1.59
|
13
|
Genomic-based therapy: targeting interleukin-1 for autoinflammatory diseases.
|
Arthritis Rheum
|
2004
|
1.58
|
14
|
Cadherin-11 provides specific cellular adhesion between fibroblast-like synoviocytes.
|
J Exp Med
|
2004
|
1.48
|
15
|
T cell repertoire development in humans with SCID after nonablative allogeneic marrow transplantation.
|
J Immunol
|
2003
|
1.39
|
16
|
Protein microarray analysis of disease activity in pediatric inflammatory bowel disease demonstrates elevated serum PLGF, IL-7, TGF-beta1, and IL-12p40 levels in Crohn's disease and ulcerative colitis patients in remission versus active disease.
|
Am J Gastroenterol
|
2005
|
1.34
|
17
|
Human ribonuclease A superfamily members, eosinophil-derived neurotoxin and pancreatic ribonuclease, induce dendritic cell maturation and activation.
|
J Immunol
|
2004
|
1.33
|
18
|
Beta-arrestin 2-dependent angiotensin II type 1A receptor-mediated pathway of chemotaxis.
|
Mol Pharmacol
|
2005
|
1.33
|
19
|
CX3CR1 tyrosine sulfation enhances fractalkine-induced cell adhesion.
|
J Biol Chem
|
2002
|
1.30
|
20
|
Acute LPS inhalation in healthy volunteers induces dendritic cell maturation in vivo.
|
J Allergy Clin Immunol
|
2005
|
1.27
|
21
|
Toll-like receptor 4 (TLR4)-deficient murine macrophage cell line as an in vitro assay system to show TLR4-independent signaling of Bacteroides fragilis lipopolysaccharide.
|
Infect Immun
|
2002
|
1.21
|
22
|
Th17 cells, not IL-17+ γδ T cells, drive arthritic bone destruction in mice and humans.
|
J Immunol
|
2011
|
1.14
|
23
|
Multiplexed protein profiling on antibody-based microarrays by rolling circle amplification.
|
Curr Opin Biotechnol
|
2003
|
1.14
|
24
|
Increased acute inflammation, leukotriene B4-induced chemotaxis, and signaling in mice deficient for G protein-coupled receptor kinase 6.
|
J Immunol
|
2003
|
1.10
|
25
|
Chemokines and leukocyte trafficking in rheumatoid arthritis.
|
Pathophysiology
|
2005
|
1.04
|
26
|
CX3CR1 deficiency confers protection from intimal hyperplasia after arterial injury.
|
Arterioscler Thromb Vasc Biol
|
2006
|
1.04
|
27
|
Ozone enhancement of lower airway allergic inflammation is prevented by gamma-tocopherol.
|
Free Radic Biol Med
|
2007
|
1.00
|
28
|
The immune system in aging: roles of cytokines, T cells and NK cells.
|
Front Biosci
|
2005
|
0.98
|
29
|
Cowpox virus encodes a fifth member of the tumor necrosis factor receptor family: a soluble, secreted CD30 homologue.
|
Proc Natl Acad Sci U S A
|
2002
|
0.96
|
30
|
Recycling of the membrane-anchored chemokine, CX3CL1.
|
J Biol Chem
|
2005
|
0.96
|
31
|
Granulocyte chemotaxis and disease expression are differentially regulated by GRK subtype in an acute inflammatory arthritis model (K/BxN).
|
Clin Immunol
|
2008
|
0.96
|
32
|
Abnormal development of thymic dendritic and epithelial cells in human X-linked severe combined immunodeficiency.
|
Clin Immunol
|
2004
|
0.93
|
33
|
Enhanced Th17-cell responses render CCR2-deficient mice more susceptible for autoimmune arthritis.
|
PLoS One
|
2011
|
0.91
|
34
|
AIRE recruits multiple transcriptional components to specific genomic regions through tethering to nuclear matrix.
|
Mol Immunol
|
2005
|
0.91
|
35
|
Defective antitumor responses in CX3CR1-deficient mice.
|
Int J Cancer
|
2007
|
0.90
|
36
|
B cell-ablative therapy for the treatment of autoimmune diseases.
|
Arthritis Rheum
|
2002
|
0.88
|
37
|
Decreased Th17 and antigen-specific humoral responses in CX₃ CR1-deficient mice in the collagen-induced arthritis model.
|
Arthritis Rheum
|
2012
|
0.87
|
38
|
The chemokine CX3CL1 regulates NK cell activity in vivo.
|
Cell Immunol
|
2003
|
0.87
|
39
|
Clustered charged amino acids of human adenosine deaminase comprise a functional epitope for binding the adenosine deaminase complexing protein CD26/dipeptidyl peptidase IV.
|
J Biol Chem
|
2002
|
0.83
|
40
|
Dual targeting of CCR2 and CX3CR1 in an arterial injury model of vascular inflammation.
|
Thromb J
|
2010
|
0.82
|
41
|
Suboptimal neurodevelopment in very preterm infants is related to fetal cardiovascular compromise in placental insufficiency.
|
Am J Obstet Gynecol
|
2005
|
0.81
|
42
|
B cell loss leading to remission in severe systemic lupus erythematosus.
|
J Rheumatol
|
2003
|
0.75
|